These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36941262)

  • 1. An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition.
    Noske GD; Song Y; Fernandes RS; Chalk R; Elmassoudi H; Koekemoer L; Owen CD; El-Baba TJ; Robinson CV; ; Oliva G; Godoy AS
    Nat Commun; 2023 Mar; 14(1):1545. PubMed ID: 36941262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
    Lockbaum GJ; Reyes AC; Lee JM; Tilvawala R; Nalivaika EA; Ali A; Kurt Yilmaz N; Thompson PR; Schiffer CA
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33503819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M
    Arutyunova E; Khan MB; Fischer C; Lu J; Lamer T; Vuong W; van Belkum MJ; McKay RT; Tyrrell DL; Vederas JC; Young HS; Lemieux MJ
    J Mol Biol; 2021 Jun; 433(13):167003. PubMed ID: 33895266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved SARS-CoV-2 main protease high-throughput screening assay using a 5-carboxyfluorescein substrate.
    Legare S; Heide F; Bailey-Elkin BA; Stetefeld J
    J Biol Chem; 2022 Apr; 298(4):101739. PubMed ID: 35182525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?
    Macip G; Garcia-Segura P; Mestres-Truyol J; Saldivar-Espinoza B; Pujadas G; Garcia-Vallvé S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection.
    Ge R; Shen Z; Yin J; Chen W; Zhang Q; An Y; Tang D; Satz AL; Su W; Kuai L
    SLAS Discov; 2022 Mar; 27(2):79-85. PubMed ID: 35063690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.
    Fischer A; Sellner M; Mitusińska K; Bzówka M; Lill MA; Góra A; Smieško M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extended conformation of SARS-CoV-2 main protease reveals allosteric targets.
    Sun Z; Wang L; Li X; Fan C; Xu J; Shi Z; Qiao H; Lan Z; Zhang X; Li L; Zhou X; Geng Y
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2120913119. PubMed ID: 35324337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.
    Liang J; Karagiannis C; Pitsillou E; Darmawan KK; Ng K; Hung A; Karagiannis TC
    Comput Biol Chem; 2020 Dec; 89():107372. PubMed ID: 32911432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.
    Deshmukh MG; Ippolito JA; Zhang CH; Stone EA; Reilly RA; Miller SJ; Jorgensen WL; Anderson KS
    Structure; 2021 Aug; 29(8):823-833.e5. PubMed ID: 34161756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.
    Silvestrini L; Belhaj N; Comez L; Gerelli Y; Lauria A; Libera V; Mariani P; Marzullo P; Ortore MG; Palumbo Piccionello A; Petrillo C; Savini L; Paciaroni A; Spinozzi F
    Sci Rep; 2021 Apr; 11(1):9283. PubMed ID: 33927258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
    Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
    mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M
    Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
    J Chem Inf Model; 2022 Dec; 62(24):6553-6573. PubMed ID: 35960688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 3CL
    Kuo CJ; Liang PH
    FEBS Lett; 2022 May; 596(9):1214-1224. PubMed ID: 35302661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
    Koudelka T; Boger J; Henkel A; Schönherr R; Krantz S; Fuchs S; Rodríguez E; Redecke L; Tholey A
    Proteomics; 2021 Jan; 21(2):e2000246. PubMed ID: 33111431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode.
    Chen S; Jonas F; Shen C; Hilgenfeld R
    Protein Cell; 2010 Jan; 1(1):59-74. PubMed ID: 21203998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine.
    Brewitz L; Dumjahn L; Zhao Y; Owen CD; Laidlaw SM; Malla TR; Nguyen D; Lukacik P; Salah E; Crawshaw AD; Warren AJ; Trincao J; Strain-Damerell C; Carroll MW; Walsh MA; Schofield CJ
    J Med Chem; 2023 Feb; 66(4):2663-2680. PubMed ID: 36757959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library.
    Lee JY; Kuo CJ; Shin JS; Jung E; Liang PH; Jung YS
    Bioorg Med Chem Lett; 2021 Jun; 42():128067. PubMed ID: 33957246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.